For the Inventor, By the Inventor

Enter assignee name

Tewksbury, MA, United States of America

Vasca, Inc.

USPTO Granted Patents = 30

% Expired Patents = 3.3

Trademarks = 1

Forward Citations = 2,565

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

James M Brugger (23 out of 199 patents)

Jeffrey H Burbank (21 out of 145 patents)

Charles David Finch (13 out of 16 patents)

4. John H Wang (9 out of 11 patents)

5. Charles David Finch, Jr (8 out of 15 patents)

6. Hendrik Klaas Kuiper (5 out of 7 patents)

7. Hendrik Klass Kuiper (3 out of 4 patents)

8. C David Finch (3 out of 6 patents)

9. Hendrik E Kuiper (3 out of 3 patents)

10. George W Buffaloe, Iv (2 out of 9 patents)

11. John R Ross (2 out of 2 patents)

12. Paul F Marad (2 out of 2 patents)

13. Gerald Beathard (2 out of 3 patents)

14. James R Tobul (1 out of 1 patent)

15. John E Moran (1 out of 1 patent)

Core Competencies:

Vascular Access

Implanted Ports

Catheter Disinfection

Dialysis Methods

Subcutaneous Grafts

Infection Prevention

Flow-Through Dialysis

Valve Port Assembly

Percutaneous Access

Implantable Devices

Cannula Methods

Fluid Infusion

30 patents: Sort by Forward Citations

1. 7056316 - Valve port and method for vascular access (2006-06-06),

2. 6929631 - Method and apparatus for percutaneously accessing a pressure activated implanted port (2005-08-16),

3. 6752827 - Devices, systems, and methods for subcutaneously placing an article (2004-06-22),

4. 6685694 - Methods and kits for locking and disinfecting implanted catheters (2004-02-03),

5. 6682498 - Methods and systems for subcutaneous graft implantation (2004-01-27),

6. 6679870 - Methods and kits for locking and disinfecting implanted catheters (2004-01-20),

7. 6592564 - Methods and kits for locking and disinfecting implanted catheters (2003-07-15),

8. 6585681 - Methods and apparatus for performing flow-through peritoneal dialysis (2003-07-01),

9. 6565525 - Valve port assembly with interlock (2003-05-20),

10. 6482197 - Methods and apparatus for inhibiting infection of subcutaneously implanted devices (2002-11-19),

11. 6436084 - Methods and apparatus for disinfecting subcutaneously implanted devices (2002-08-20),

12. 6398764 - Subcutaneously implanted cannula and method for arterial access (2002-06-04),

13. 6299610 - Methods and apparatus for disinfecting subcutaneously implanted devices (2001-10-09),

14. 6299609 - Methods and apparatus for inhibiting infection of subcutaneously implanted devices (2001-10-09),

15. 6258079 - Method and systems for establishing vascular access (2001-07-10),

Company Overview

Vasca, Inc. is a technology-focused company based in Tewksbury, Massachusetts, specializing in innovative solutions for the healthcare sector. The organization develops advanced medical devices and software aimed at enhancing patient care and streamlining clinical workflows. With a commitment to research and development, Vasca leverages cutting-edge technologies to address critical challenges in medical diagnostics and treatment, positioning itself as a key player in the evolving landscape of healthcare technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

30 Patents

#5 in Tewksbury, MA

#671 in Massachusetts

#11,272 in US

#21,888 in the World

Tewksbury, MA, United States of America

Vasca, Inc.

Forward Citations = 2,565

16 inventors:

James M Brugger (23 out of 199 patents)

Jeffrey H Burbank (21 out of 145 patents)

Charles David Finch (13 out of 16 patents)

4. John H Wang (9 out of 11 patents)

5. Charles David Finch, Jr (8 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vasca, Inc.. Retrieved from https://idiyas.com/company/vasca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…